You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BMS-986205

Showing 1 - 25 of 820
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +7 more
  • IDO1 Inhibitor BMS-986205
  • Nivolumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Advanced Cancer Trial in Hangzhou (BMS-986205, Nivolumab)

Completed
Has Results
  • Advanced Cancer
  • BMS-986205
  • Nivolumab
  • Hangzhou, Zhejiang, China
    Local Institution
Feb 3, 2022

Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)

Recruiting
  • Lip
  • +4 more
  • Nivolumab
  • +3 more
  • Columbus, Ohio
  • +1 more
Oct 25, 2021

Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

Active, not recruiting
  • Endometrial Adenocarcinoma
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 29, 2021

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • BMS-986205
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Urinary Bladder Tumors Trial in Worldwide (Nivolumab, BCG, BMS-986205)

Completed
  • Urinary Bladder Neoplasms
  • Nivolumab
  • +2 more
  • Los Angeles, California
  • +88 more
Jan 24, 2023

Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • BMS-986205
  • +2 more
  • Los Angeles, California
  • +62 more
Jun 18, 2021

Glioblastoma Trial in Chicago (biological, radiation, drug)

Recruiting
  • Glioblastoma
  • IDO1 Inhibitor BMS-986205
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 30, 2020

Urinary Bladder Tumors, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • Muscle-Invasive Bladder Cancer
  • Nivolumab
  • +2 more
  • Tucson, Arizona
  • +172 more
Jan 25, 2023

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Boston (Nivolumab, BMS-986205, Ipilimumab)

Withdrawn
  • Melanoma Stage III
  • Melanoma Stage IV
  • Boston, Massachusetts
  • +1 more
Feb 3, 2020

Healthy Trial in Austin (BMS-986205, omeprazole)

Completed
  • Healthy
  • Austin, Texas
    PPD Phase I Clinic
Sep 19, 2019

Advanced Cancer Trial in Chuo-ku (BMS-986205, Nivolumab)

Completed
  • Advanced Cancer
  • BMS-986205
  • Nivolumab
  • Chuo-ku, Tokyo, Japan
    Local Institution
Mar 29, 2019

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Head Neck Cancer Trial in Pittsburgh (Nivolumab, BMS-986205, Cetuximab)

Withdrawn
  • Head and Neck Cancer
  • Nivolumab
  • +5 more
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Apr 16, 2019

Healthy Participants Trial in Nottingham (BMS-986205)

Completed
  • Healthy Participants
  • BMS-986205
  • Nottingham, Ruddington Fields, United Kingdom
    Quotient Clinical
Jun 26, 2018

Healthy Volunteers Trial in Austin (BMS-986205 reference tablet, BMS-986205 tablet with free base)

Completed
  • Healthy Volunteers
  • BMS-986205 reference tablet
  • BMS-986205 tablet with free base
  • Austin, Texas
    PPD Austin Clinic
Feb 26, 2018

Malignancies Multiple Trial in Austin (BMS-986205, Itraconazole, Rifampin)

Completed
  • Malignancies Multiple
  • BMS-986205
  • +2 more
  • Austin, Texas
    PPD
Feb 26, 2018

Healthy Male Volunteers Trial in Madison ([14C]-BMS-986196)

Not yet recruiting
  • Healthy Male Volunteers
  • Madison, Wisconsin
  • +1 more
Aug 1, 2023

Healthy Participants Trial (BMS-986465, Placebo, Pegasys)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Nov 17, 2023

Calcium Citrate Absorption, Calcium Carbonate Absorption Trial in Alexandria (The absorption effect between calcium citrate and

Not yet recruiting
  • Calcium Citrate Absorption
  • Calcium Carbonate Absorption
  • The absorption effect between calcium citrate and calcium carbonate
  • Alexandria, Egypt
    The surgical department of Medical Research Institute Hospital,
Sep 15, 2023

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)

Not yet recruiting
  • Burning Mouth Syndrome
  • topical placebo tablet
  • +5 more
  • (no location specified)
Sep 10, 2023

Healthy Adult Volunteers Trial (BMS-986196)

Not yet recruiting
  • Healthy Adult Volunteers
  • (no location specified)
Sep 6, 2023